Redeye comments on Formpipe’s Q3, showing ARR growth and EBITDA-CAPEX in line with our expectations.
DT’s CMD outlined strategy for the next five years.
GiG Software Q3-results were in line with our expectations while the company reiterated its guidance...
Redeye comments on Mendus announcing a directed share issue.
Redeye returns with an updated view following Nekkar’s soft Q3 figures driven by Syncrolift, while F...
Redeye provides an update following Corline’s Q3 2025 report.
Redeye comments on Lytix' third quarter report 2025.
Redeye return with a research update following BioArctic's Q3 report and latest newsflow.
Q3 visade intäktstapp och ett justerat rörelseresultat på 4 Mkr, men totalt stora förluster efter en...
Redeye provides an initial take following the release of Corline’s Q3 2025 report.
Redeye comments on Gentoo Media’s Q3-results which were softer than expected owing to a weaker-than-...
Lipum and Flerie have agreed to merge in a transaction that will see Lipum absorbed into Flerie in e...
Redeye comments on Fable Media Group taking the anticipated step toward a higher dividend, further f...
Som förväntat inga större nyheter. Möjlig liten försening av finansieringspaketet, vägs upp av möjli...
Redeye provides a research update following Dala Energi’s Q3 report, published last Friday.
Redeye comments on Friday’s press release from Waystream, stating it has signed a strategic partners...
Kentima visar stark tillväxt med en omsättningsökning på 36 procent i Q3, drivet av bredare efterfrå...
Thunderful enters 2026–2027 with a release pipeline that shows potential, albeit with some uncertain...
Redeye updates on Embracer after Q2-results which were slightly better than expected driven by Enter...
Redeye gives a short comment on the news that the FDA has accepted Ascelia’s NDA application for Orv...
